Cancer pharmacogenomics in children: research initiatives and progress to date.

about

Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.Pharmacogenetics of anthracyclines.Tissue Engineering Strategies as Tools for Personalized Meningioma Treatment.

P2860

Q34483451-937BDFDD-397E-459E-A20B-5EBE22F9D096 Q38856218-76998588-9A79-4AE7-B896-2AF22E22990F Q38884421-5FCBF567-D5C7-4DD3-B8C2-108A31A2A6F3

P2860

Cancer pharmacogenomics in children: research initiatives and progress to date.

Item

http://www.wikidata.org/entity/Q38093137

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cancer pharmacogenomics in children: research initiatives and progress to date.

@en

type

Item

label

Cancer pharmacogenomics in children: research initiatives and progress to date.

@en

prefLabel

Cancer pharmacogenomics in children: research initiatives and progress to date.

@en

P1476

Cancer pharmacogenomics in children: research initiatives and progress to date

@en

P2093

Bruce C Carleton

http://www.w3.org/2001/XMLSchema#string

Colin J D Ross

http://www.w3.org/2001/XMLSchema#string

Michael R Hayden

http://www.w3.org/2001/XMLSchema#string

Shahrad Rod Rassekh

http://www.w3.org/2001/XMLSchema#string

P2860

Initial sequencing and analysis of the human genome

The Sequence of the Human Genome

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance

Risk factors for doxorubicin-induced congestive heart failure

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

Genetic variability in CYP3A5 and its possible consequences.

P2888

s40272-013-0021-9

P304

71-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40272-013-0021-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1050782625

http://www.w3.org/2001/XMLSchema#string

P698

23529868

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

Cancer pharmacogenomics in children: research initiatives and progress to date.

about

P2860

P2860

Cancer pharmacogenomics in children: research initiatives and progress to date.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921